Key facts
- This page summarizes Jae B. Kim's Form 3 filing for Design Therapeutics, Inc. (DSGN).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2024, 19:57.
Jae B. Kim - 13 Mar 2024 Form 3 Insider Report for Design Therapeutics, Inc. (DSGN)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- DSGN
- Reported as of
- 13 Mar 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 20 Mar 2024, 19:57:52 UTC
- Next SEC filing
- 24 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mustapha Parekh, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jae B. Kim filed Form 3 for Design Therapeutics, Inc. (DSGN) on 20 Mar 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DSGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,756
- Date
- 13 Mar 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DSGN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 315,000
- Exercise price
- $12.77
- Footnotes
- F1
DSGN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 115,000
- Exercise price
- $7.97
- Footnotes
- F2
DSGN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 175,000
- Exercise price
- $2.54
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares subject to the option will vest as follows: 25% of the shares vested on January 24, 2023, and the balance will vest in equal monthly installments thereafter over a three year period.
Footnote F2
The shares subject to the option will vest as follows: 20% of the shares vested on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.
Footnote F3
The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.